The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Lilly's stock meanders, but remains a Buy

 Oct 01, 2009 09:40 PM UTC
Return Risk
+1.63% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
LLY Positive 10/01/09 +14.24% --

Graphic_arrow1 Via BloggingStocks:  

Filed under: Lilly (Eli) (LLY), Stocks to Buy

Eli Lilly & Co. (NYSE: LLY) stock has unexpectedly meandered since the June 8, 2009 Buy recommendation at a price of $34.10, but the aforementioned probably represents selected investor jitters about the likely, federal health care reform legislation.

Ignore those jitters. The major components of health care reform have not been determined as of September 30, 2009, but the pharma calculation remains the same as it was in June. The legislation will be net-positive for major pharmaceutical companies, under the thesis that there will be 30-45 million more U.S. residents regularly - as opposed to sporadically - accessing health care services over the next decade, not including population growth.

Continue reading Lilly's stock meanders, but remains a Buy

Lilly's stock meanders, but remains a Buy originally appeared on BloggingStocks on Thu, 01 Oct 2009 16:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati




 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch